Clinical Trial Update: Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese Adults [Phase 4]

View source ↗

Summary

This clinical trial update reports on a Phase 4 study of Orlistat (Xenical) for four years of weight-loss maintenance in adults with obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Orlistat (Xenical) (orlistat)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Obesity | Phase 4 | Status: COMPLETED